וויגובי 1.7 מג

Țară: Israel

Limbă: ebraică

Sursă: Ministry of Health

Ingredient activ:

SEMAGLUTIDE

Disponibil de la:

NOVO NORDISK LTD., ISRAEL

Codul ATC:

A10BJ06

Forma farmaceutică:

תמיסה להזרקה

Compoziție:

SEMAGLUTIDE 2.27 MG / 1 ML

Calea de administrare:

תת-עורי

Tip de prescriptie medicala:

מרשם נדרש

Produs de:

NOVO NORDISK A/S, DENMARK

Zonă Terapeutică:

SEMAGLUTIDE

Data de autorizare:

2023-04-23

Prospect

1
ʥ"ʮʹʺʤ (ʭʩʸʩʹʫʺ) ʭʩʧʷʥʸʤ ʺʥʰʷʺ ʩʴʬ
ʯʫʸʶʬ ʯʥʬʲ
-
1986
ʩʡʥʢʩʥʥ
®
0.25
ʢ"ʮ
ʩʡʥʢʩʥʥ
®
0.5
ʢ"ʮ
ʩʡʥʢʩʥʥ
®
1
ʢ"ʮ
ʩʡʥʢʩʥʥ
®
1.7
ʢ"ʮ
ʩʡʥʢʩʥʥ
®
2.4
ʢ"ʮ
ʤʷʸʦʤʬ ʤʱʩʮʺ
ʨʲʡ
ʹʥʮʩʹʬ ʯʫʥʮ
ʸʮʥʧ
ʬʩʲʴ
0.25
"
0.68
"
/
"
semaglutide 0.68 mg/ml -
0.5
"
1.34
"
/
"
semaglutide 1.34 mg/ml -
1
"
1.34
"
/
"
semaglutide 1.34 mg/ml -
1.7
"
2.27
"
/
"
semaglutide 2.27 mg/ml -
2.4
"
3.2
"
/
"
-
semaglutide 3.2 mg/ml
:
2
"
"
6
."
"
ʹʺ ʭʸʨʡ ʥʴʥʱ ʣʲ ʯʥʬʲʤ ʺʠ ʯʥʩʲʡ ʠʸʷ
ʺ
.ʤʴʥʸʺʡ ʹʮ
.
,
.
.
.
.
1
.
ʤʮʬ
ʺʣʲʥʩʮ
ʤʴʥʸʺʤ
?
,
,
,
)
BMI
(
:

≤
30
/
"
2
)
(

BMI
≤
27
/
"
2
>
30
/
"
2
)
(
,
;
)
-
2
,(
,(
)
,
)
(
.
)
BMI
(
.
:ʺʩʨʩʥʴʸʺ ʤʶʥʡʷ
,
-
1
)
GLP-1
(
-
1
)
GLP-1
,(
.
,
(
)
,
,
.
.
2
2
.
ʩʰʴʬ
ʹʥʮʩʹʤ
ʤʴʥʸʺʡ
:ʭʠ ʤʴʥʸʺʡ ʹʮʺʹʤʬ ʯʩʠ

(
)
)
6
.(
ʤʴʥʸʺʡ ʹʥʮʩʹʬ ʺʥʲʢʥʰʤ ʺʥʣʧʥʩʮ ʺʥʸʤʦʠ
ʡ ʬʥʴʩʨʤ ʩʰʴʬ
ʩʡʥʢʩʥʥ
:ʭʠ ʠʴʥʸʬ ʸʴʱ ,
,
.
:


1




.(
)
:

75


(
)
,
.
.

ʺʥʹʡʩʩʺʤ
,
,
.
.(
)
.
.
.

ʡʬʡʬʤ
ʺʷʬʣ
)
4
(
–
)
.(

ʩʬʥʧ
ʢʥʱʮ ʺʸʫʥʱ
2
.
GLP-1
)
,
,
.(

(ʤʩʮʷʩʬʢʥʴʩʤ) ʭʣʡ ʤʫʥʮʰ ʸʫʥʱ ʺʮʸ
.(
)
4
.
.
.

ʺʬʧʮ
(ʤʩʺʴʥʰʩʨʸ) ʺʩʺʸʫʥʱ ʭʩʩʰʩʲ
,
.
,
.
.
,
ʭʩʸʢʡʺʮʥ ʭʩʣʬʩ
18
,
.
3
ʩʡ ʺʥʡʥʢʺ
ʯ
-
ʺʥʩʺʴʥʸʺ
ʺʠ ʭʠ
ʤ
,ʤʰʥʦʺ ʩʴʱʥʺʥ ʭʹʸʮ ʠʬʬ ʺʥʴʥʸʺ ʬʬʥʫ
ʺʥʸʧʠ ʺʥʴʥʸʺ ,ʤʰʥʸʧʠʬ ʺʧʷʬ ʭʠ ʥʠ ,ʧʷʥʬ
.ʧʷʥʸʬ ʥʠ ʠʴʥʸʬ ʪʫ ʬʲ ʸʴʱ
:

)
,
.(
.
ʤʷʰʤʥ ʯʥʩʸʩʤ
.
.
.
,
,
.
.
,
ʺʥʰʥʫʮʡ ʹʥʮʩʹʥ ʤʢʩʤʰ
)
(
.
,
)
4
,
.(
,
,
.
.
_יוח_
_ _
_ גוסמ תר וס_
_2_
_ _
,
.
,(
)
.
2
"
"
4
.
.
ʤʴʥʸʺʤ ʬʹ ʭʩʡʩʫʸʮʤʮ ʷʬʧ ʬʲ ʡʥʹʧ ʲʣʩʮ
-
1
)
23
( "
."
"
,
3
.
ʣʶʩʫ
ʹʮʺʹʺ
ʤʴʥʸʺʡ
?
.
.
.
:
2.4
.
"
,
16
.

,
0.25
"
.

4
2.4
.
"
�